approval
saveSTELARA (USTEKINUMAB) — FDA approval
community read0 votes
Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalSTELARA (USTEKINUMAB) — FDA approvalApr 15, 2026 · 174d ago
- approvalSTELARA (USTEKINUMAB) — FDA approvalJun 27, 2025 · 466d ago
- approvalSTELARA (USTEKINUMAB) — FDA approvalApr 1, 2025 · 553d ago
- approvalSTELARA (USTEKINUMAB) — FDA approvalNov 15, 2024 · 690d ago
- approvalSTELARA (USTEKINUMAB) — FDA approvalMar 18, 2024 · 932d ago
- approvalSTELARA (USTEKINUMAB) — FDA approvalMar 6, 2023 · 1310d ago
- approvalSTELARA (USTEKINUMAB) — FDA approvalJul 29, 2022 · 1530d ago
- approvalSTELARA (USTEKINUMAB) — FDA approvalDec 11, 2020 · 2125d ago
same company · ±60 days · 6
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 6, 2025
- approvallazertinib mesylate: LAZCLUZE (LAZERTINIB MESYLATE) — FDA approvalNov 7, 2025
- approvalamivantamab: RYBREVANT (AMIVANTAMAB-VMJW) — FDA approvalNov 7, 2025
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 14, 2025
- approvalSIMPONI (GOLIMUMAB) — FDA approvalOct 22, 2025
- approval(daratumumab + hyaluronidase (human recombinant)): DARZALEX FASPRO (DARATUMUMAB AND HYALURONIDASE-FIHJ) — FDA approvalNov 19, 2025
🐶 often sniffed alongside
top 8- tagApproval270 co-mentions · 91 sources
- drugSTELARA223 co-mentions · 91 sources
- tagOrthopedics60 co-mentions · 30 sources
- companyJanssen Biotech Inc28 co-mentions · 14 sources
- drugPYZCHIVA26 co-mentions · 13 sources
- drugOTULFI18 co-mentions · 9 sources
- companySamsung Bioepis Co Ltd13 co-mentions · 13 sources
- drugWEZLANA12 co-mentions · 6 sources
comments(0)
5-min edit window · permanent after that